US-based Jubilant Cadista Pharmaceuticals is recalling over 5,700 bottles of Bupropion Hydrochloride extended-release tablets, used to treat major depressive disorder, from the US market. The company is a fully-owned subsidiary of Cadista Holdings Inc, which is a part of the Noida-based Jubilant Life Sciences Company.
As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), the Salisbury-based Jubilant Cadista is recalling the drug for "failed dissolution specifications". The voluntary recall initiated by the company includes 3,072 bottles of 30 count and 2,688 bottles of 90 count.
A mail sent to the company to obtain comments remained unanswered. In October 2018, Jubilant Cadista Pharmaceuticals had recalled over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets, manufactured by Jubilant Generics Ltd at its Roorkee plant, from the America and Puerto Rico market.
(With inputs from agencies.)